Bebo Health (XPAR:MLBBO) ROCE %: 12.84% (As of Dec. 2025)


XPAR:MLBBO Bebo Health SA XPAR:MLBBO
47 GF Score
Price €0.23
GF Value €0.03
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Bebo Health ROCE %?

Bebo Health XPAR:MLBBO 47 ROCE % is 12.84% as of Dec. 2025. GuruFocus rates XPAR:MLBBO with a GF Score™ of 47/100 and a GF Value™ of €0.03 (Significantly Overvalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Bebo Health's annualized ROCE % for the quarter that ended in Dec. 2025 was 12.84%.

Bebo Health  (XPAR:MLBBO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Bebo Health ROCE % Related Terms

Bebo Health ROCE % Historical Data

* Premium members only.

The historical data trend for Bebo Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bebo Health ROCE % Chart

Bebo Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial 2.27 1.41 3.19 -0.21 12.84

Bebo Health Semi-Annual Data
Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE % Get a 7-Day Free Trial 2.27 1.41 3.19 -0.21 12.84
XPAR:MLBBO
47GF Score
Bebo Health SA XPAR:MLBBO
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bebo Health ROCE % Calculation

Bebo Health's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=1.621/( ( (11.932 - 2.474) + (26.64 - 10.846) )/ 2 )
=1.621/( (9.458+15.794)/ 2 )
=1.621/12.626
=12.84 %

Bebo Health's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Dec. 2024 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Dec. 2024 )(Q: Dec. 2025 )
=1.621/( ( (11.932 - 2.474) + (26.64 - 10.846) )/ 2 )
=1.621/( ( 9.458 + 15.794 )/ 2 )
=1.621/12.626
=12.84 %

(1) Note: The EBIT data used here is one times the annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 12.84% mean?
Bebo Health (XPAR:MLBBO) has a ROCE % of 12.84% as of Dec. 2025.
Is Bebo Health's ROCE % too high?
Bebo Health's current ROCE % is 12.84%. The Retail - Cyclical industry median ROCE % is 7.60. Bebo Health's value of 12.84% is 69.1% above this industry median. Overall, Bebo Health has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bebo Health's ROCE % compare to CASY and WSM?
Bebo Health's ROCE % of 12.84% can be compared against companies in the Retail - Cyclical industry. The industry median ROCE % is 7.60. Bebo Health's value of 12.84% is 69.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Retail - Cyclical company?
The median ROCE % among Retail - Cyclical companies is 7.60, based on 1,112 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bebo Health's current ROCE % of 12.84% is 69.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Retail - Cyclical industry, the median ROCE % is 7.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bebo Health's current ROCE % is 12.84%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bebo Health stock overvalued right now?
Based on GuruFocus' analysis, Bebo Health (XPAR:MLBBO) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.03, compared to a current price of €0.23 — trading 660% above its estimated fair value. The current ROCE % is 12.84% and 69.1% above the Retail - Cyclical industry median of 7.60. Bebo Health's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Bebo Health (XPAR:MLBBO), the current ROCE % is 12.84% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bebo Health (XPAR:MLBBO) Overvalued in 2026?

Based on GuruFocus' analysis, Bebo Health stock appears to be overvalued. The current stock price of €0.23 is trading 660% above its estimated GF Value™ of €0.03. GuruFocus considers Bebo Health to be Significantly Overvalued.

Key valuation signals for XPAR:MLBBO:

  • ROCE %: 12.84%
  • GF Value™: €0.03 vs. price of €0.23 (660% above fair value)
  • GF Score™: 47/100 with 3 warning signs
  • Industry Position: 69.1% above the Retail - Cyclical median

No single metric tells the full story. See the XPAR:MLBBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bebo Health Business Description

Address 1 Rue de la Cite, Geneve, CHE, 1204
Bebo Health SA is a multilingual e-commerce portal specializing in products dedicated to health, sport and wellness.
47GF Score

Get the complete analysis for XPAR:MLBBO

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.23
Price
€0.03
GF Value